Cargando…

Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients

BACKGROUND: It has been reported that triple negative phenotype is characterized by aggressive clinical history in Western breast cancer patients, however its pattern of metastatic spread had never been reported in the Chinese population. Considering racial disparities, we sought to analyze the spre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yanping, Yin, Wenjin, Yan, Tingting, Zhou, Liheng, Di, Genhong, Wu, Jiong, Shen, Zhenzhou, Shao, Zhimin, Lu, Jinsong
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760577/
https://www.ncbi.nlm.nih.gov/pubmed/19778431
http://dx.doi.org/10.1186/1471-2407-9-342
_version_ 1782172761703055360
author Lin, Yanping
Yin, Wenjin
Yan, Tingting
Zhou, Liheng
Di, Genhong
Wu, Jiong
Shen, Zhenzhou
Shao, Zhimin
Lu, Jinsong
author_facet Lin, Yanping
Yin, Wenjin
Yan, Tingting
Zhou, Liheng
Di, Genhong
Wu, Jiong
Shen, Zhenzhou
Shao, Zhimin
Lu, Jinsong
author_sort Lin, Yanping
collection PubMed
description BACKGROUND: It has been reported that triple negative phenotype is characterized by aggressive clinical history in Western breast cancer patients, however its pattern of metastatic spread had never been reported in the Chinese population. Considering racial disparities, we sought to analyze the spread pattern for different sites of first recurrence in Chinese triple negative breast cancers. METHODS: A retrospective study of 1662 patients was carried out from a large database of breast cancer patients undergoing surgery between January 1, 2000 and March 31, 2004 at the Cancer Hospital, Fudan University, Shanghai, China. Survival curves were generated using the Kaplan-Meier method and annual relapse hazards were estimated by the hazard function. RESULTS: We found a statistically significant difference in relapse-free survival (RFS) for locoregional and visceral recurrence (P = 0.007 and P = 0.025, respectively) among the triple negative, ERBB2+ and HR+/ERBB2- subgroups in univariate analysis. In the multivariate Cox proportional hazards regression analysis, RFS for either locoregional or visceral relapse in the triple negative category was inferior to that in HR+/ERBB2- patients (P = 0.027 and P = 0.005, respectively), but comparable to that in ERBB2+ women (both P >0.05). Furthermore, the early relapse peak appeared later in the triple negative group than that in the ERBB2+ counterpart for both locoregional and visceral relapse. On the other hand, when compared with triple negative breast cancers, a significantly lower risk of developing bone relapse was discerned for ERBB2+ women (P = 0.048; HR = 0.384, 95% CI 0.148-0.991), with the borderline significance for HR+/ERBB2- breast cancers (P = 0.058; HR = 0.479, 95% CI 0.224-1.025). In terms of bone metastasis, the hazard rate remained higher for the triple negative category than that for the ERBB2+ subtype. CONCLUSION: Based on the site-specific spread pattern in different subgroups, the triple negative category of breast cancers in the Chinese population exhibits a different pattern of relapse, which indicates that different organotropism may be due to the different intrinsic subtypes. A better knowledge of the triple negative category is warranted for efficacious systemic regimens to decrease and/or delay the relapse hazard.
format Text
id pubmed-2760577
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27605772009-10-13 Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients Lin, Yanping Yin, Wenjin Yan, Tingting Zhou, Liheng Di, Genhong Wu, Jiong Shen, Zhenzhou Shao, Zhimin Lu, Jinsong BMC Cancer Research Article BACKGROUND: It has been reported that triple negative phenotype is characterized by aggressive clinical history in Western breast cancer patients, however its pattern of metastatic spread had never been reported in the Chinese population. Considering racial disparities, we sought to analyze the spread pattern for different sites of first recurrence in Chinese triple negative breast cancers. METHODS: A retrospective study of 1662 patients was carried out from a large database of breast cancer patients undergoing surgery between January 1, 2000 and March 31, 2004 at the Cancer Hospital, Fudan University, Shanghai, China. Survival curves were generated using the Kaplan-Meier method and annual relapse hazards were estimated by the hazard function. RESULTS: We found a statistically significant difference in relapse-free survival (RFS) for locoregional and visceral recurrence (P = 0.007 and P = 0.025, respectively) among the triple negative, ERBB2+ and HR+/ERBB2- subgroups in univariate analysis. In the multivariate Cox proportional hazards regression analysis, RFS for either locoregional or visceral relapse in the triple negative category was inferior to that in HR+/ERBB2- patients (P = 0.027 and P = 0.005, respectively), but comparable to that in ERBB2+ women (both P >0.05). Furthermore, the early relapse peak appeared later in the triple negative group than that in the ERBB2+ counterpart for both locoregional and visceral relapse. On the other hand, when compared with triple negative breast cancers, a significantly lower risk of developing bone relapse was discerned for ERBB2+ women (P = 0.048; HR = 0.384, 95% CI 0.148-0.991), with the borderline significance for HR+/ERBB2- breast cancers (P = 0.058; HR = 0.479, 95% CI 0.224-1.025). In terms of bone metastasis, the hazard rate remained higher for the triple negative category than that for the ERBB2+ subtype. CONCLUSION: Based on the site-specific spread pattern in different subgroups, the triple negative category of breast cancers in the Chinese population exhibits a different pattern of relapse, which indicates that different organotropism may be due to the different intrinsic subtypes. A better knowledge of the triple negative category is warranted for efficacious systemic regimens to decrease and/or delay the relapse hazard. BioMed Central 2009-09-24 /pmc/articles/PMC2760577/ /pubmed/19778431 http://dx.doi.org/10.1186/1471-2407-9-342 Text en Copyright ©2009 Lin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lin, Yanping
Yin, Wenjin
Yan, Tingting
Zhou, Liheng
Di, Genhong
Wu, Jiong
Shen, Zhenzhou
Shao, Zhimin
Lu, Jinsong
Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
title Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
title_full Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
title_fullStr Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
title_full_unstemmed Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
title_short Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
title_sort site-specific relapse pattern of the triple negative tumors in chinese breast cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760577/
https://www.ncbi.nlm.nih.gov/pubmed/19778431
http://dx.doi.org/10.1186/1471-2407-9-342
work_keys_str_mv AT linyanping sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients
AT yinwenjin sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients
AT yantingting sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients
AT zhouliheng sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients
AT digenhong sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients
AT wujiong sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients
AT shenzhenzhou sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients
AT shaozhimin sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients
AT lujinsong sitespecificrelapsepatternofthetriplenegativetumorsinchinesebreastcancerpatients